Summary
Signal counts
Assets tracked: 1
Watchlist assets: 1
Registry stop assets: 0
Sponsor overview
Mabwell (Shanghai) Bioscience Co., .
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT05216965 | https://clinicaltrials.gov/study/NCT06823427 | https://clinicaltrials.gov/study/NCT06492005
Assets
Linked programs
- 9MW2821: Timeline Staleness Signal (5/5)